Change Schedule: Cannabis Products and Evidence Review

change schedule: This change to the Misuse of Drugs Regulations 2001 was partly a response to a rapid evidence review by the chief medical officer, which concluded that some medicinal cannabis products were effective for some medical conditions, and partly due to formal advice from the government's Advisory Council on the Misuse of Drugs to change the schedule, according to The Independent. Perhaps a more powerful driver of the rescheduling was a well-organised publicity campaign discussing the treatment of sick children that was compelling, emotional and difficult to challenge. Medicinal cannabis products were moved from schedule 1, meaning they have no medicinal value, to schedule 2, which allowed doctors to prescribe them under certain circumstances. The campaign used confrontational tactics, had large financial backing and privileged access to national media and senior politicians. Meet the nuns who rake in 850k a year growing and selling cannabis Show all 7 Created with Sketch. But did the wave of public support lead to unrealistic expectations about accessing medicinal cannabis Created with Sketch. (news.financializer.com). As reported in the news.